High-risk acute coronary syndrome patients and cardiac biomarkers in the emergency department: Any role for new biomarkers of myocardial ischaemia? [3]

European Heart Journal

Volumn 28, Issue 18, 2007, Pages 2297-

  Roy, Debashis ^a   Kaski, Juan Carlos ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; FIBRINOGEN RECEPTOR ANTAGONIST; LOW MOLECULAR WEIGHT HEPARIN; TROPONIN;

ACUTE CORONARY SYNDROME; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; LETTER; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; EMERGENCY SERVICE, HOSPITAL; HUMANS; MYOCARDIAL ISCHEMIA; RISK FACTORS;

EID: 34548789675     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehm301     Document Type: Letter

References (8)

1. Bagwe S, Sachdeva R, Mehta J. High-risk acute coronary syndrome patient and cardiac biomarkers in the emergency department: where do we stand? Eur Heart J 2007;28:1043-1044.
2. Miller CD, Banerjee A, Mahaffey KW, Kontos MC, Fermann G, Pollack CV, Antman E, Aylward P, Goodman SG, Santos R, Ferguson JJ, Califf RM, Hoekstra JW. Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trial. Eur Heart J 2007;28:1079-1084.
3. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003;107:2403-2405.
4. Sinha MK, Roy D, Gaze D, Collinson PO, Kaski JC. Role of 'Ischemia Modified Albumin', a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004;21:29-34.
5. Peacock F, Morris D, Anwaruddin S, Christenson R, Collinson P, Goodacre SW, Januzzi JL, Jesse RL, Kaski JC, Kontos MC, Lefevre G, Mutrie D, Sinha MK, Uettwiller-Geiger D, Pollack CV. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006;152:253-262.
6. Sinha MK, Vazquez JM, Calvino R, Gaze DC, Collinson PO, Kaski JC. Effect of balloon occlusion during percutaneous coronary intervention on circulating ischemia modified albumin and transmyocardial lactate extraction. Heart 2006;92:1852-1853.
7. Roy D, Quiles J, Sinha M, Floros D, Gaze D, Collinson P, Baxter GF, Kaski JC. Effect of radiofrequency catheter ablation on the biochemical marker ischemia modified albumin. Am J Cardiol 2004;94:234-236.
8. Roy D, Quiles J, Gaze D, Collinson PO, Kaski JC, Baxter GF. Role of reactive oxygen species in the formation of the novel diagnostic marker ischemia modified albumin. Heart 2006;92:113-114.